WHOOP raises $575m at $10.1bn valuation to expand AI health platform

WHOOP has raised $575 million in new funding at a valuation of $10.1 billion, as it accelerates its ambition to build a global platform for personalized, preventive healthcare powered by artificial intelligence and biometric data.

The Series G round was led by the Collaborative Fund and attracted participation from a mix of institutional investors, private equity funds and healthcare leaders, including Qatar Investment Authority and Mubadala Investment Company. Strategic support also came from Abbott and the Mayo Clinic, highlighting the growing convergence between technology and traditional health care systems.

The round also attracted individual investors from around the world of sports and entertainment, including Cristiano Ronaldo, LeBron James and Rory McIlroy, demonstrating WHOOP’s strong relationship with fitness and high health.

The investment comes at a time when healthcare systems around the world are under increasing pressure from rising rates of chronic disease and an aging population. WHOOP is at the forefront of the transition from active treatment to preventive, data-driven health management.

Founder and CEO Will Ahmed said the company is building a platform designed to help individuals monitor, understand and continuously improve their health.

“We are creating a personalized health system that allows people to improve their performance and long-term health,” he said.

At the core of the platform is continuous biometric monitoring, combined with AI models trained on more than 24 billion hours of physiological data. This allows WHOOP to deliver personal data on sleep, recovery, stress and physical activity, as well as early indicators of potential health risks.

WHOOP has experienced strong growth in recent years, with more than 2.5 million members worldwide and bookings up 103 percent by 2025 to reach a running average of $1.1 billion. The company also reported positive cash flow during the year, underlining its financial strength.

The new funding will support further expansion in key global markets, including Europe, the Gulf region, Latin America and Asia, as well as continued growth in the United States.

To support this expansion, WHOOP plans to hire more than 600 additional employees worldwide, focusing on research, development and innovation of new products.

The involvement of established healthcare organizations such as Abbott marks a broader shift in integrating consumer technology with clinical expertise.

By combining wearable technology with advanced analytics, WHOOP aims to provide a holistic view of health, allowing users to make informed decisions about their lifestyle and potentially prevent serious conditions before they develop.

The platform’s high engagement levels, with users opening the app multiple times a day, highlight the growing need for real-time health information that goes beyond traditional fitness tracking.

While WHOOP initially gained traction with athletes and high-performance individuals, the company is now targeting a wider audience, including executives, professionals and consumers looking to improve both health and productivity.

The focus is increasingly on “healthspan”, the length of time people stay healthy and active, rather than just being alive.

Cristiano Ronaldo, investor and ambassador, described the platform as an important tool to manage his life, showing its position at the intersection of work and wellness.

The latest funding round reinforces WHOOP’s position as one of the most important players in the rapidly expanding digital health sector.

As advances in AI and data analytics continue to reshape healthcare, companies that can combine technology, user engagement and clinical relevance are expected to play a key role in the future of the industry.

For WHOOP, the challenge now is to scale its platform globally while maintaining accuracy, trust and regulatory compliance, turning wearable data into meaningful, actionable health outcomes at scale.